AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 51 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.06 and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $413,000 | -29.6% | 700,000 | -35.6% | 0.06% | -24.1% |
| Q4 2016 | $587,000 | -39.4% | 1,087,715 | 0.0% | 0.08% | -26.2% |
| Q3 2016 | $968,000 | -7.4% | 1,087,715 | 0.0% | 0.11% | -27.7% |
| Q2 2016 | $1,045,000 | +4.4% | 1,087,715 | 0.0% | 0.15% | -2.0% |
| Q1 2016 | $1,001,000 | -27.0% | 1,087,715 | 0.0% | 0.15% | -7.9% |
| Q4 2015 | $1,371,000 | -28.6% | 1,087,715 | -31.5% | 0.16% | -46.6% |
| Q3 2015 | $1,921,000 | -30.5% | 1,587,715 | 0.0% | 0.31% | -16.3% |
| Q2 2015 | $2,763,000 | – | 1,587,715 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
| X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
| WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
| Caption Management, LLC | 855,200 | $701,000 | 0.04% |
| Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
| Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |